“Phase I Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects with Actinic Keratosis”, J of Skin, vol. 4, no. 6, p. s119, Oct. 2020, doi: 10.25251/skin.4.supp.119.